跳至主要内容
临床试验/CTRI/2024/09/074367
CTRI/2024/09/074367尚未招募不适用

To Evaluate the Efficacy and Safety of Earthful Women 40 plus Supplement in Menopause Symptom Management and Quality of Life improvement in Perimenopause and Postmenopausal (Menopause) Women.

Kenzen Ventures Private Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
1.Changes in global scores of Menopausal Rating Scale (MRS). .The MRS Scale Measures the following parameters: (11 points - hot

研究概览

简要总结

Menopausal symptoms severely reduce the quality of life of post-menopausal women worldwide. Nutraceuticals are widely prescribed as a viable and safer alternative and complementary approach to standard therapies. The aim of this study was to evaluate the clinical efficacy and safety of a nutraceutical in post-menopausal women.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
40.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Perimenopausal women and postmenopausal women in the age group of 40 to 65 years.
  • Participants who are apparently healthy.
  • Women who have at least 5 points of MRS score.
  • Calcium deficiency Biomarkers.

排除标准

  • Perimenopausal women and postmenopausal women in the age group of 40 to 65 years.
  • Participants who are apparently healthy.
  • Women who have at least 5 points of MRS score.
  • Calcium deficiency Biomarkers.

结局指标

主要结局

1.Changes in global scores of Menopausal Rating Scale (MRS). .The MRS Scale Measures the following parameters: (11 points - hot

时间窗: 1. (Day 0, Day30, Day | 60 & Day 90) | 2.Day 0 & Day 90

flashes, mood swings , anxiety, fatigue ,Body pains,sleep disturbances, vaginal

时间窗: 1. (Day 0, Day30, Day | 60 & Day 90) | 2.Day 0 & Day 90

dryness)

时间窗: 1. (Day 0, Day30, Day | 60 & Day 90) | 2.Day 0 & Day 90

2. Calcium Biomarkers

时间窗: 1. (Day 0, Day30, Day | 60 & Day 90) | 2.Day 0 & Day 90

次要结局

  • 1. Change in the frequency and severity of hot flushes(2. Change in the frequency and severity of night sweats.)

研究者

发起方
Kenzen Ventures Private Limited
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Sanjana Kumari Vt

Sri Lakshmi Hospital

研究点 (1)

Loading locations...

相似试验